HIF1A and hepatocellular carcinoma: Our results depicted attenuation in mRNA and protein expression levels of Hif1- α, VEGF and Akt upon taxifolin treatment in HepG2 and Huh7 cells, suggesting taxifolin can be a viable option for curbing cell survival and angiogenesis in hepatic carcinoma.